Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AABFV06371
Vitamines D3 K2 MK7 Pure à 100 % 240 Comprimés Vegan, Combinaison Vit D3 4000 ui et Vitamine K2 125 μg
midtail
3P
PARAPHARMACIE LIBRE-SERVICE
Last 4 weeks demand
5
▼ 16.7% vs prev 4w
Offer Stock
6
Σ Stock across 1 live offer (1P + 3P) · 2026-10-02
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-02 snapshot
Unit price
MAD 243
avg of last 30 sells · latest 2026-09-25
AABFV06371
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-09-28 · Total forecast: 449 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Vitamines D3 K2 MK7 Pure à 100 % 240 Comprimés Vegan, Combinaison Vit D3 4000 ui et Vitamine K2 125 μg · in the midtail cohort · last 4 weeks 5 units, trending down -16.7% · on-hand 7 units
Signals the model saw
- Cohort: midtail (371 days of history, 270 units sold over 52 weeks)
- Volatility (CV): 0.90 — moderate
- Recent trend: last 4w = 5 units · prev 4w = 6 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 0.7 units |
| Realistic forecast — next 4 weeks | 4.4 units |
| Realistic forecast — next 3 months | 123.7 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 13.0 units |
| Optimistic — next week | 12.0 units |
| Optimistic — next 4 weeks (reorder target) | 65.8 units |
| Optimistic — next 3 months (quarterly PO target) | 448.5 units |
| Legacy μ/wk (reorder pipeline) | 3.2 |
| Revenue exposure — optimistic, 3 months | MAD 108.8K |